NATCO Pharma Investor Relations Material
Latest events
Q1 25/26
NATCO Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from NATCO Pharma Limited
Access all reports
NATCO Pharma Limited is a pharmaceutical company specializing in the development, manufacturing, and marketing of generic and specialty pharmaceuticals. The company produces a range of pharmaceutical products, including oncology, cardiology, and central nervous system medications, focusing on affordable therapies for complex health conditions. NATCO Pharma serves both domestic and international markets, providing formulations and active pharmaceutical ingredients (APIs) to healthcare providers and distributors. The company is headquartered in Hyderabad, India, and its shares are listed on the NSE and BSE.
Key slides for NATCO Pharma Limited
M&A Announcement
NATCO Pharma Limited
Q1 25/26
NATCO Pharma Limited
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
NATCOPHARM
Country
🇮🇳 India